Assessing Adherence to Adjuvant Hormone Therapy in Breast Cancer Patients in Routine Clinical Practice

BACKGROUND: Adjuvant hormone therapy (HT) in patients with hormone receptor-positive breast cancer (BC) increases overall survival (OS). A lack of adherence to adjuvant endocrine therapy is common, 31.0-73.0% of women discontinue endocrine treatment before 5 years. The aim of the study was to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Camejo, Natalia, Castillo, Cecilia, Tambasco, Clara, Strazzarino, Noelia, Requena, Nicolas, Peraza, Silvina, Boronat, Anna, Herrera, Guadalupe, Esperon, Patricia, Cuello, Mauricio, Krygier, Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409554/
https://www.ncbi.nlm.nih.gov/pubmed/37560342
http://dx.doi.org/10.14740/wjon1647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409554/
https://www.ncbi.nlm.nih.gov/pubmed/37560342
http://dx.doi.org/10.14740/wjon1647

Ejemplares similares